SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31

SOLESENCE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.89−0.01 (-0.81%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2011 to 2025

25.9%−9.1 pts over 5 years

2.5%−6.1 pts over 5 years

2.9%−2.9 pts over 5 years

Compound annual growth to fiscal 2025

Per year	1 year	3 years	5 years	10 years
Revenue	+18.6%	+18.5%	+29.4%	+19.7%
Gross profit	-0.8%	+24.3%	+21.8%	+17.8%
Operating income	-69.4%	–	+1.1%	–
Net income	-57.7%	–	+12.6%	–
EPS, diluted	-71.4%	–	-7.8%	–

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2016	FY2020	FY2025
Return on equity	-45.4%	46.6%	14.6%
Return on assets	-27.3%	8.6%	3.7%
Current ratio	2.64	1.30	1.81
Debt to equity	–	0.53	–
Net debt to EBITDA	–	0.27×	–
Interest coverage	-84.5×	3.0×	–
Inventory turnover	10.5×	3.2×	2.6×
Capex to revenue	1.2%	5.1%	–
Diluted shares	31M	39M	73M

Return on equity split into margin, efficiency and leverage

Net margin2.9%

Asset turnover1.29×

Equity multiplier3.95×

Return on equity, FY202514.6%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2025	2.9%	1.29×	3.95×	14.6%
FY2024	8.1%	1.26×	6.76×	69.1%
FY2023	-11.8%	1.12×	8.80×	-116.3%
FY2022	-7.0%	1.20×	4.72×	-40.0%
FY2021	7.9%	1.41×	4.11×	45.5%
FY2020	5.8%	1.49×	5.40×	46.6%
FY2019	-24.0%	1.57×	5.51×	-207.7%
FY2018	-14.7%	2.21×	2.78×	-90.2%
FY2017	-6.3%	2.25×	1.84×	-26.2%
FY2016	-11.9%	2.29×	1.67×	-45.4%